3,4-methylenedioxyamphetamine has been researched along with Leprosy in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Leprosy: A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Correia, JC | 1 |
| Golay, A | 1 |
| Lachat, S | 1 |
| Singh, SB | 1 |
| Manandhar, V | 1 |
| Jha, N | 1 |
| Chappuis, F | 1 |
| Beran, D | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Leprosy
| Article | Year |
|---|---|
"If you will counsel properly with love, they will listen": A qualitative analysis of leprosy affected patients' educational needs and caregiver perceptions in Nepal.
Topics: Adolescent; Adult; Caregivers; Counseling; Female; Health Knowledge, Attitudes, Practice; Humans; Le | 2019 |